ECOFENAC CR cpr 150 mg 30 pce

7680555130082 CH-55513 M01AB05 07.10.1.
ECOFENAC CR cpr 150 mg 30 pce
ECOFENAC CR cpr 150 mg 30 pce
ECOFENAC CR cpr 150 mg 30 pce
1 / 3
google

Details

Product number
5551302
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
diclofenacum natricum 150 mg, lactosum monohydricum 83.5 mg, hypromellosum, cellulosum microcristallinum, calcii hydrogenophosphas dihydricus, maydis amylum, carboxymethylamylum natricum A, silica colloidalis anhydrica, magnesii stearas, aqua, E 172 (rubrum), pro compresso corresp. natrium 11 mg.

Articles (1)

Ecofenac CR 150, Zweischichttabletten
Zweischichttabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
83.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
11.0 MG Substance HBESI

Reimbursement information

Public price
CHF 32.95
Specialties list
Yes
Generic
Yes
SL addition date: 01/07/2001

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
55513
Drug name
Ecofenac CR, Zweischichttabletten
Galenic form
RETT
ATC Code
M01AB05
Authorization status
Z
Dispensation category
B
First authorization
29/11/2000
Authorization expiration date
31/12/9999
IT number
07.10.1.
Domain
Human medicine
Field of application
Antirheumatikum

Packaging details

Description (FR)
ECOFENAC CR cpr 150 mg 30 pce
Description (DE)
ECOFENAC CR Tabl 150 mg 30 Stk
Market launch
29/11/2000
Narcotic (BTM)
No

Original drug

Diclofenac-Mepha, Injektionslösung i.m.
CHF 12.40
View original

Other packaging sizes

ECOFENAC CR cpr 75 mg 20 pce
20 TABL
View
ECOFENAC CR cpr 75 mg 100 pce
100 TABL
View
ECOFENAC CR cpr 150 mg 10 pce
10 TABL
View
ECOFENAC CR cpr 150 mg 100 pce
100 TABL
View